CUSIP 16385C203SPONSORED ADSCMMBQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
14 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Citadel Advisors LLC | 103.8K | $171.2K | +103.8K | New |
| 2 | Adar1 Capital Management, LLC | 80.0K | $132.0K | +80.0K | New |
| 3 | Ikarian Capital, LLC | 51.8K | $85.5K | −1.5K | Reduced |
| 4 | Kestra Private Wealth Services, LLC | 51.7K | $85.3K |
| +51.7K |
| New |
| 5 | Xtx Topco Ltd | 19.0K | $31.4K | +19.0K | New |
| 6 | Rhumbline Advisers | 17.9K | $29.5K | +8.4K | Added |
| 7 | Jane Street Group, LLC | 15.6K | $25.7K | −5.9K | Reduced |
| 8 | Bnp Paribas Financial Markets | 8.1K | $13.4K | +2.4K | Added |
| 9 | Morgan Stanley | 3.8K | $6.2K | −86.3K | Reduced |
| 10 | Gamma Investing LLC | 2.5K | $4.1K | +1.8K | Added |
See every fund holding Chemomab Therapeutics Ltd, with full quarter-over-quarter share changes.
Unlock all holders